Human papillomavirus and cervical cancer behavioral surveillance in the US

Jasmin A. Tiro, Mona Saraiya, Nidhi Jain, Nicole Liddon, Vilma Cokkinides, Sue Min Lai, Nancy Breen, Louise Wideroff

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


In the US, federal and state behavioral surveillance systems routinely monitor self-reported sexual behavior and Papanicolaou (Pap) test use to identify high-risk populations, trends, and disparities and to guide and evaluate interventions for cervical cancer prevention and control. Clinical uptake of human papillomavirus (HPV) vaccination and testing necessitates the expansion of behavioral surveillance systems. Cervical disease is the main focus of HPV-related behavioral surveillance because of greater cancer incidence and mortality relative to other susceptible organs, and the availability of effective technologies for prevention and control. In the current study, a framework is presented for the types of behaviors to monitor, their conceptual and operational definitions, target populations, and evidence supporting the reliability and validity of self-report measures. An overview is also provided of 8 population-based and 2 provider-based data systems that are nationally representative and accessible for behavioral surveillance research. Ongoing surveillance at the national, state, and local level is critical for monitoring the dissemination of HPV technologies and their impact on reducing disparities in the detection of precursor lesions, incidence of invasive cancer, and mortality.

Original languageEnglish (US)
Pages (from-to)3013-3030
Number of pages18
Issue number10 SUPPL.
StatePublished - Nov 15 2008


  • Behavioral surveillance
  • Cervical cancer
  • Human papillomavirus
  • Papanicolaou test use

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Human papillomavirus and cervical cancer behavioral surveillance in the US'. Together they form a unique fingerprint.

Cite this